Taysha Gene Therapies (TSHA) Amortizatization of Intangibles (2022 - 2026)
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Taysha Gene Therapies | 2.06 Bn | 2.06 Bn | - | 271,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 271,000.00 |
| Mar 31, 2026 | 285,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 308,000.00 |
| Mar 31, 2025 | 339,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 297,000.00 |
| Jun 30, 2024 | 294,000.00 |
| Mar 31, 2024 | 325,000.00 |
| Dec 31, 2023 | 274,000.00 |
| Sep 30, 2023 | 305,000.00 |
| Jun 30, 2023 | 303,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Sep 30, 2022 | 385,000.00 |
| Jun 30, 2022 | 337,000.00 |
| Mar 31, 2022 | 309,000.00 |